Latest

The Key to Better Navigating VUCA Industry Conditions

Alison Horstmeyer discusses how pharma executives can apply four attributes of curiosity to negotiate VUCA (volatile, uncertain, complex, and ambiguous) conditions and improve organizational outcomes.

Design Thinking in Pharma

When design thinking is incorporated into the business model, pharmaceutical businesses can truly differentiate themselves and recognize a valuable impact, writes Adam Taicher.

Patient- & Customer-Centric Commercialization: A Case Study

Outlining a real-world example in which building and operationalizing a patient- and customer-centric commercialization strategy drove a successful launch from a “standing start.”

Opioid Litigation: Evading the Widening Crosshairs

The role of insurance and risk management in protecting middle-market distributors from the growing opioid multi-district litigation (MDL).

Pharm Exec Video

Behind the Scenes with Kallyope’s Nancy Thornberry

A sneak peek at Pharm Exec's August cover shoot with the New York City-based biotech CEO.

Why One Korean Biotech Picked New Jersey for U.S. Headquarters

New Jersey is still a top pick for companies when it comes to pharma.

Pharm Exec Talks Partnerships with Sanofi

Hear what Sanofi looks for when they decide to form a partnership with another company.

New & Noteworthy

Opioid Litigation: Evading the Widening Crosshairs

The role of insurance and risk management in protecting middle-market distributors from the growing opioid multi-district litigation (MDL).

Fixing the Broken Search Process

Traditional scientific search is broken. AI-supported smart searching is the answer, writes Jane Reed.

Compliance: The Critical Cog in Pharma Machine

Pharm Exec convenes an expert panel to discuss new ways to navigate the many complexities of assessing business and risk in the life sciences.

Japan: Balancing Cost and Innovation through Pricing

Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.

Sales & Marketing

Patient Communications: Why Pharma Leaders Should Think Like Social Marketers

By exploring how social marketers think, pharma can unlock tried-and-tested ways to bring measurable value to their patients, write Patrick Ladbury and Oliver Childs.

Connecting the 5 Spheres of People-Based Marketing

From persistent identity to cloud marketing driven by AI, managing holistic experience is now the hallmark of brand leadership. Croom Lawrence and Kent Groves explains how people-based marketing plays a key role.

Leveraging Lab Data in Advent of Personalized Marketing

Laboratory testing has become a critical access point for sales teams in the age of personalized medicine, writes Melissa Leonhauser.

eBooks

Emerging BioPharma: Your Guide to Clinical and Commercial Considerations

This eBook will focus on the specific needs and concerns of the smaller to mid-size biopharmaceutical company. Articles cover considerations from Phase II to commercial pathways. 

View all eBooks

PEspeaks

European Drug Innovators Face Tough Fight to Maintain Research Incentives

Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector.

Blockchain 101 for Pharma Executives

With blockchain still in the potential but not proven area of the pharma enterprise, when is the technology the right choice for you?

China’s Biopharma Rise: Opportunities and Threats

Peter Young explores the prospects—and related challenges—for Chinese life science as it aggressively pursues new growth areas.

Pharm Exec's Top 50 Companies 2018

Pharm Exec’s 18th annual listing of the top biopharma players shows that most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth.

Interviews

Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersys

PharmExec talks to Dr. Gil Van Bokkelen, co-founder of Athersys, a company looking to forge new advances in the stem cell arena.

EMA Relocation Countdown: Some Industry Viewpoints

Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.

Regulatory Information Management: Current and Future States

Steve Gens talks to Pharm Exec about the evolution of Regulatory Information Management (RIM) and offers some predictions for 2022.

Regulatory

EMA Relocation Countdown: Some Industry Viewpoints

Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.

Regulatory Innovation Generates Breakthroughs

Streamlined clinical research, more guidance speed new cures to patients. Jill Wechsler reports.

Congress, Feds, FDA Take Action to Combat Opioid Crisis

Jill Wechsler details recent bipartisan action to support treatment of opioid abusers and deter inappropriate drug prescribing and illegal distribution.

From the Editor

Blockchain 101 for Pharma Executives

With blockchain still in the potential but not proven area of the pharma enterprise, when is the technology the right choice for you?

Insights for the Win

Lisa Henderson reports on the takeaways from last month's annual gathering of the Pharm Exec Editorial Advisory Board.

lorem ipsum